Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Registrational Pivotal Phase III Study of Olverembatinib for the First-Line Treatment of Patients with Ph+ ALL Approved by the CDE in China 2023-07-06 10:38
United Imaging, Kicking off a Birthday Celebration of Five Years in the U.S. Market, Will Debut Three New Scanners at AHRA 2023-07-06 00:00
Biosion, Inc. Appoints Furqan Ahmed, PharmD as Vice President and Head of Business Development 2023-07-05 22:05
PENTAX MEDICAL ANNOUNCES THE APPOINTMENT OF DAVID HARRISON AS THE NEW PRESIDENT FOR THE AMERICAS 2023-07-05 21:00
Lunit Makes Full-Fledged Entry into the Middle East with Participation in 'Saudi Vision 2030' Healthcare Transformation Project 2023-07-05 21:00
I-Mab Announces Publication of Claudin18.2 x 4-1BB Bispecific Antibody Givastomig in JITC 2023-07-05 20:00
TiumBio and Hansoh Pharma Announce Clinical Trial Approval of 'HS-10518/TU2670' from NMPA in China 2023-07-05 20:00
BGI CEO Yin Ye Advocates for Global Technology Sharing 2023-07-05 14:17
Jacobio Receives CDE Approval for Glecirasib's Pancreatic Cancer Pivotal Study in China 2023-07-04 21:16
Positive guidance from US FDA on Cu-64 SAR-bisPSMA Phase III trial in prostate cancer 2023-07-04 20:55
China NMPA approves RareStone's pitolisant (Wakix) for the treatment of narcolepsy 2023-07-04 20:42
Lunit's AI-Powered Lung Cancer Screening Solution Significantly Affects Radiologists' Diagnostic Determination - Published in Radiology 2023-07-03 21:00
Skyline Therapeutics Receives FDA Clearance of IND for SKG0106, a Novel Intravitreally Delivered AAV Gene Therapy Candidate for Neovascular Age-related Macular Degeneration 2023-07-03 19:00
Henlius Forecasts Profit in 1H 2023 2023-07-03 17:49
Zymedi announced their collaboration with the National Heart, Lung, and Blood Institute through a CTA CRADA to develop ZMA001 mAb, a potential treatment for Pulmonary Arterial Hypertension (PAH), a rare, female predominant disease 2023-07-03 08:00
Chime Biologics Announces Strategic Cooperation with Leads Biolabs and BeiGene to Advance LBL-007 mAb Development and Manufacturing Globally 2023-06-30 20:15
Harbour BioMed Announces Biologics License Application Acceptance of Batoclimab for Treatment of Generalized Myasthenia Gravis by NMPA 2023-06-29 21:26
Jowell Global Ltd. Granted Extension to Meet Nasdaq Minimum Bid Price Requirement 2023-06-29 20:00
HaemaLogiX Announces Positive Final Results from KappaMab Combination Phase IIb Myeloma Trial 2023-06-29 19:00
Jacobio Pharma Presents Clinical Results of Glecirasib in Colorectal Cancer 2023-06-29 16:31
1 87 88 89 90 91 812